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Malignancy Rate in Sonographically Suspicious Thyroid Nodules 
of Less than a Centimeter in Size Does Not Decrease with 
Decreasing Size
We evaluated the malignancy and nondiagnostic rates using fine needle aspiration 
cytology (FNAC) results in thyroid nodules smaller than 1 cm according to the subdivided 
size. We retrospectively reviewed the medical records of all subjects underwent FNAC from 
2003 to 2009 in our hospital, and 2,756 patients of subcentimeter thyroid nodules with 
one or more suspicious sonographic features and 7,105 with nodule sized 1 cm or more 
were included. The malignancy rate was higher in those subcentimeter nodules with 
suspicious sonographic findings than the nodule sized 1cm or more (19.7% vs 7.8%, P < 
0.001). We grouped the nodules based on size with mm interval and observed that the 
malignancy rate did not decrease but the nondiagnostic results increased its size 
decrement. When we divided the subjects arbitrarily into a 5 mm or smaller and a 6-9 mm 
sized group, nondiagnostic cytology findings were reported more frequently in the smaller 
group (24.3% vs 18.1%, P = 0.001), while the rate of “malignant” was similar (18.3% vs 
15.5%, P = 0.123) and the rate of “suspicious for malignancy” was higher (6.8% vs 2.9%, 
P < 0.001). Therefore when we decide to perform FNAC or not in subcentimeter-sized 
nodules, we should consider sonographic findings and other clinical risk factors but not the 
nodular size itself. 
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INTRODUCTION
The development of high-resolution ultrasound has made it 
possible to detect many nonpalpable thyroid nodules. The inci-
dence of thyroid nodules is known to be about 70% in the gen-
eral adult population, and about 5%-15% of the nodules are ma-
lignant (1). Especially, the increasing thyroid cancer incidence 
in the recent decade has been thought resulting from the in-
creased detection of small subcentimeter-sized thyroid cancers 
(microcarcinoma) by ultrasound (2, 3). However, still contro-
versies exist any cut-off size to discriminate the malignancy risk 
or prognosis in subcentimeter thyroid cancers. 
  Some previous studies showed that thyroid cancers larger 
than 5 mm had more lymph node metastasis than those 5 mm 
or smaller in papillary thyroid microcarcinoma (4, 5), and pap-
illary carcinomas of sizes up to 5 mm showed significantly bet-
ter recurrence-free survival rates compared to those between 6 
and 10 mm (6). Based on these results, in the revised American 
Thyroid Association Guidelines, they recommend performing 
fine needle aspiration cytology (FNAC) on thyroid nodules larg-
er than 5 mm with suspicious sonographic features for patients 
with high-risk histories. However, there is still controversy sur-
rounding the management of subcentimeter thyroid nodules 
with suspicious sonographic features. To make recommenda-
tions about the indication of FNAC in subcentimeter thyroid 
nodules, it is also important to know the malignancy rates and 
the diagnostic yields of ultrasound-guided FNAC as well as the 
prognosis of subcentimeter-sized thyroid cancer.
  To evaluate whether there exist any valuable cut-off size pre-
dicting the malignancy in subcentimeter-sized thyroid nodules 
with suspicious sonographic findings, we compared the malig-
nancy rate and the diagnostic yields upon FNAC results accord-
ing to the subdivided size.
MATERIALS AND METHODS
Subjects
Between May 2003 and September 2009, ultrasound (US)-guid-Bo YH, et al.  •  Malignancy Rate of FNAC in Subcentimeter Thyroid Nodule
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ed FNAC was performed on a total of 9,861 thyroid nodules at 
Seoul National University Bundang Hospital. We retrospective-
ly reviewed the medical records of all subjects and collected de-
mographic data and information about the size of the nodules 
on which FNAC was performed and their FNAC results. The 
mean size of the nodules was 1.72 ± 1.13 cm (median 1.38 cm; 
range 0.14-9.92 cm). The mean age of the patients was 51.1 ± 
12.1 yr. Of the nodules, 2,756 (27.9%) were smaller than 1 cm 
with a mean size of 0.70 ± 0.18 cm (median 0.71 cm; range 0.14-
0.99 cm), and the mean age of the patients with these nodules 
was 50.3 ± 11.4 yr. 
  The US-guided FNAC was performed by several radiologists 
with the use of a Philips iU 22 (Royal Philips Electronics, Amster-
dam, The Netherlands), which employs electronically focused 
near-field probes with a bandwidth of 7-12 MHz. For the nod-
ules that had not undergone FNAC previously, FNAC was per-
formed in thyroid nodules of 1 cm or more in size or in the sub-
centimeter nodules that had at least one sonographic finding 
suggestive of malignancy. Sonographic characteristics associat-
ed with malignancy were defined as hypoechogenicity, an ori-
entation taller-than-wide, the presence of calcification or irreg-
ular margins (7). In the nodules that were confirmed to be be-
nign by the previous FNAC results, repeated FNACs were taken 
only for the nodules showing either 2 or more suspicious fea-
tures or an increase in size during the follow-up examination. 
We treated the FNAC results for the nodules that underwent re-
peated FNACs as different nodules in this study. For the FNAC, 
23-gauge needles were used without local anesthesia. A 26-gauge 
needle was used if profuse bleeding occurred. 
Cytologic examination
Aspiration samples were dispersed onto slides and fixed by air-
drying. Samples were then stained with either hematoxylin and 
eosin or Giemsa and evaluated by the pathology department of 
our hospital. The cytology findings of the nodules were reviewed 
by experienced pathologists and categorized as “benign”, “in-
determinate”, “suspicious of follicular or Hürthle cell neoplasm”, 
“suspicious of malignancy”, “malignancy” or “nondiagnostic” 
(8). We defined the malignancy rate as the proportion of find-
ings classified as both “suspicious of malignancy” and “malig-
nancy” because the expected true malignancy rates were report-
ed to be 60%-75% and 97%-99%, respectively (8). Thus, physi-
cians usually recommend surgery in both cases. Benign nod-
ules included adenomatous goiters, nodular hyperplasia, lym-
phocytic thyroiditis, degenerative nodules and other benign 
conditions.
Statistical analysis
To compare the cytologic findings, the chi-square test was per-
formed using the SPSS software (SPSS, Inc., Chicago, IL, USA). 
A two-tailed P value of less than 5% was considered statistically 
significant. Univariate odds ratios (OR), with relative 95% confi-
dence intervals (CI), were calculated to assess the ability of clin-
ical characteristics to predict the results of FNAC.
Ethics statement
The institutional review board of Seoul National University Bun-
dang Hospital approved this study protocol (B-1006-103-121) 
and waived the informed consent requirement for retrospective 
evaluation of the medical record.
RESULTS
The malignancy rate of subcentimeter sized thyroid 
nodules with sonographically suspicious findings
The malignancy rate was higher in subcentimeter-sized nodules 
with suspicious sonographic features than in nodules sized 1 cm 
or more (malignancy rate 19.7% vs 7.8%, P < 0.001; the rate of 
“malignancy” 16.0% vs 7.0%, P < 0.001; the rate of “suspicious 
for malignancy” 3.6% vs 0.8%, P < 0.001). The nondiagnostic 
rate in subcentimeter nodules was higher than the rate in nod-
ules sized 1 cm or larger (19.3% vs 13.8%, P < 0.001) (Table 1). 
Table 1. Cytological diagnosis according to nodule sizes
Size of nodules  < 1.0 cm*  ≥ 1.0 cm P
Number 2,756 7,105
Age (yr) 50.3 ± 11.4 51.5 ± 12.4  < 0.001
Sex (M/F) 550/2,206 1,526/5,579 0.096
Size nodule; mean ± SD (ranges) 0.70 ± 0.18 
(0.14-0.99)
2.11 ± 1.10 
(1.00-9.92)
< 0.001
Malignancy rate (n) 19.7% (542)   7.8% (553) < 0.001
Cytologic results
   Benign
   Atypia of undetermined significance
   Suspicious for follicular neoplasm
   Suspicious for malignancy
   Malignant
   Nondiagnostic
 
   47.8% (1,318)
12.1% (334)
1.1% (31)
  3.6% (100)
16.0% (442)
19.3% (531)
 
   68.4% (4,862)
  7.3% (517)
  2.7% (190)
0.8% (56)
  7.0% (497)
13.8% (983)
 
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
*Thyroid nodules showed one or more sonographically suspicious findings; hypoecho-
genicity, an orientation taller-than-wide, presence of calcification or irregular margin.
Table 2. Cytological diagnosis according to the nodule sizes in subcentimeter nodule 
with suspicious sonographic features
Size of nodules  ≤ 0.5 cm  0.6-0.9 cm P
Number 514 2,242
Age (yr) 50.1 ± 11.1  50.3 ± 11.5 0.688
Sex (M/F) 86/428 464/1,778 0.043
Size nodule; mean ± SD 0.43 ± 0.07 0.76 ± 0.13 < 0.001
Malignancy rate   25.1% (129) 18.4% (413) 0.001
Cytologic results
   Benign
   Atypia of undetermined  
      significance
   Suspicious for follicular  
      neoplasm
   Suspicious for malignancy
   Malignant
   Nondiagnostic
 
  35.6% (183)
14.0% (72)
1.0% (5)
  6.8% (35)
18.3% (94)
  24.3% (125)
 
   50.6% (1,135)
11.7% (262)
1.2% (26)
2.9% (65)
15.5% (348)
18.1% (406)
 
< 0.001
0.146
0.717
< 0.001
0.123
0.001Bo YH, et al.  •  Malignancy Rate of FNAC in Subcentimeter Thyroid Nodule
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The malignancy rates in subcentimeter-sized thyroid 
nodules
When we compared the rate of “malignant”, “suspicious of ma-
lignant” or malignancy rate among the mm-sized groups, we 
could not find any difference and there was no cut-off size to dis-
criminate the difference (data not shown). Because some pa-
pers have suggested the use of 0.5 cm as a size threshold for de-
termining whether or not surgical treatment is indicated (4, 6), 
we divided the subcentimeter nodules arbitrarily into groups 
consisting of nodules that were 5 mm or smaller (n = 514) and 
nodules that were larger than 5 mm (n = 2,242) (Table 2). The 
rate of “malignant” was similar between those two groups (18.3% 
vs 15.5%, P = 0.123), while the rate of “suspicious for malignan-
cy” was higher in smaller group (6.8% vs 2.9%, P < 0.001). In uni-
variated or mutivariated analysis, including both “suspicious 
malignancy” and “malignant” results, the malignancy rate was 
higher in smaller nodules (Table 3).
Age of patients associated with a high risk of malignancy 
in subcentimeter-sized thyroid nodules
We analyzed the malignancy rates according to the size, age or 
sex of the subjects to determine whether or not these clinical 
parameters could be useful in deciding when to perform an ul-
trasound-guided FNAC. Sex was not associated with an increased 
risk of malignancy in subcentimeter-sized thyroid nodules. When 
age was expressed as either categorical variables or continuous 
variables, both univariate and multivariate analysis revealed 
that younger age than 45 yr was associated with an increased 
risk of malignancy in subcentimeter nodules undergone FNAC 
(Table 3).
The rate of nondiagnostic results of FNAC
Nondiagnostic cytology findings also occurred more frequently 
in the 5 mm or smaller group (24.3% vs 18.1%, P = 0.001) (Table 
2), and there exists a trend of increasing nondiagnostic results 
with its size decrement (P value for trend < 0.001) (Fig. 1). The 
rate of nondiagnostic results of FNAC was highest (28.4%) in the 
0.4-0.49 mm sized nodules.
DISCUSSION
Our data showed that the malignancy rate in nodules that un-
derwent FNAC did not decrease with decreasing size for sub-
centimeter nodules with suspicious sonographic features. The 
overall malignancy rate was 16.0% in subcentimeter nodules, 
which is higher than 7.6% in nodules that were 1 cm or larger. A 
direct comparison of these two groups was not possible because 
FNAC was performed regardless of sonographic features in cas-
es of nodules with size 1 cm or more, while in subcentimeter 
nodules, the FNAC was performed only in nodules showing one 
or more sonographically suspicious findings. The sonographic 
criteria for malignant thyroid nodules are more sensitive than 
the size criteria for prediction of thyroid cancer (9), resulting the 
higher malignancy rate in subcentimeter nodules. However, it 
is still unclear whether the malignancy rate among sonographi-
cally-suspicious subcentimeter nodules differs according to their 
size. With the development of high-resolution ultrasound, there 
increases the prevalence of thyroid micro-nodules, so it is im-
Table 3. Univariated and multivariated analysis of clinical characteristics for malignancy rate in patient with subcentimeter thyroid nodule
Variables Group % (n) Malignancy rate % (n) P Odds ratio (95% CI) Corrected P Odds ratio (95% CI)
Size ≤ 0.5 cm
0.6-0.9 cm
Continuous variable
25.1 (129)
18.4 (413)
 
 
   0.001
< 0.001
 
0.674 (0.537-0.845)
0.347 (0.206-0.586)
 
   0.001
< 0.001
 
0.669 (0.533-0.839)
0.354 (0.209-0.598)
Sex Female
Male
21.5 (118)
19.2 (424)
 
   0.238
 
1.148 (0.913-1.444)
 
   0.175
 
1.173 (0.931-1.477)
Age < 45
≥ 45
Continuous variable
22.8 (205)
18.2 (337)
 
  
   0.004
   0.001
  
0.754 (0.620-0.916)
0.985 (0.977-0.994)
  
   0.004
   0.001
  
0.752 (0.618-0.915)
0.986 (0.978-0.994)
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Size (cm)
(P for trend < 0.001)
Nondiagnostic % (n)   25.6 (30)  28.4 (61)  23.3 (87)  22.4 (96)  16.7 (89)  16.9 (93)  13.9 (75)
  0.1-0.3  0.4  0.5  0.6  0.7  0.8  0.9
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0 Fig. 1. The nondiagnostic rate of 
FNAC was increased by decreas- 
ing nodules in subcentimeter 
sized thyroid nodules.Bo YH, et al.  •  Malignancy Rate of FNAC in Subcentimeter Thyroid Nodule
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portant to know the cut-off size discriminating an increasing 
risk of malignancy. However little is known at date. To evaluate 
this, we categorized the subcentimeter nodules with 1 mm in-
tervals, and found that in subcentimeter nodules showing any 
of suspicious sonographic features, the malgnancy rates were 
quite similar regardless of their size. Statistically, the malignan-
cy rate (the total rate of suspicious of malignancy and malignant) 
in the small nodules sized 5 mm or less was resulted even higher 
than the larger nodules. Because of the high nondiagnostic re-
sult in the smaller nodules, we could not say whether the actual 
malignancy rate is really higher in the smaller nodules, but we 
can conclude at least that the malgnancy rate is not lower in the 
smaller nodules than the larger. Thus, nodular size itself could 
not be used as a predictive factor of malignancy, and it is rea-
sonable to consider the malignancy risk of thyroid nodule de-
pend on its sonographic finding or other clinical risk factors, 
but not on its size.
  To determine whether or not FNAC is indicated for subcenti-
meter nodules, it is important to know not only about the ma-
lignancy risk but also the prognosis of thyroid microcarcinoma. 
The prognosis of thyroid cancer according to tumor size has been 
debated for years. In some studies, they reported the influence 
of the size of the primary tumor on survival among patients with 
papillary cancer was negligible for tumors less than 4 cm in di-
ameter (10, 11). Other investigators have reported that tumor-
related deaths are rare in patients with papillary thyroid tumors 
smaller than 1.0 cm (12), suggesting that microcarcinomas may 
not require immediate surgical treatment (13). However, de-
spite the excellent overall prognosis for patients with papillary 
microcarcinoma, this type of microcarcinoma was associated 
with a 1.0% disease-related mortality rate, a 5.0% lymph node 
recurrence rate, and a 2.5% distant metastasis rate in other stud-
ies. We also reported that clinicopathological features, long-term 
prognosis, and immunohistochemical findings did not differ 
between patients with papillary microcarcinoma and papillary 
thyroid cancer (14, 15). All these results support the contrary 
opinions that papillary microcarcinoma should be treated in 
the same manner as conventional papillary thyroid cancer (16). 
Although cancer-related death has rarely been reported in pa-
tients with papillary microcarcinoma, tumor recurrence may 
be associated with tumor size in papillary microcarcinoma (17). 
Recurrences require another surgery, additional radioactive io-
dine treatment, or both, which lowers the quality of life and in-
curs additional costs. Considering this, it is also important to 
reduce the risk of recurrence as well as mortality in patients with 
papillary microcarcinoma. Therefore there existed some efforts 
to find the adequate cut-off size to be evaluated, but still show 
controversy. Thus, we tried to know then whether there existed 
a cut-off size to predict malignancy, but could not find. Even the 
malignancy rate was similar between nodules sized 0.5 cm or 
less and those with diameters between 0.6 and 0.9 cm (Table 2).
  In addition to the malignancy risk and prognosis, the cost-ef-
fectiveness of FNAC should be carefully considered. There are 
only a few published reports regarding the adequacy of FNAC 
for diagnosing thyroid nodules smaller than 1 cm in maximum 
diameter (18-21). Thus, we also evaluated the diagnostic yield 
in the same subjects. The overall nondiagnostic rate was 19.3% 
and the nondiagnostic rate was increased with decreasing nod-
ule size (Fig. 1). In the literature, the adequacy rate of ultrasound-
guided FNAC ranges from 68% (22) to over 90% (23). Similar to 
our study, a study reported that the adequacy rate of FNAC was 
associated with the size of the nodule (24). Thus we should con-
sider and explain to patients about the possibility of nondiagno-
sis before performing FNAC. However, in our study, the maxi-
mum nondiagnosis rate did not exceed 30% in the subdivided 
groups. Although the adequacy rate of FNAC is quite dependent 
on the experience of the radiologist, FNAC at our institute was 
performed by several different radiologists, thus we can assume 
the nondiagnostic rate in subcentimeter nodules might be sim-
ilar in many other hospitals. Therefore, the diagnostic yield of 
small nodules should not be an absolute reason to avoid per-
forming FNAC in subcentimeter nodules.
  In addition, we investigated age or sex could impact the like-
lihood of malignancy of the nodules. Berker et al. (18) reported 
that thyroid cancer affects more women than men, however the 
gender of patients did not predict the malignancy of subcenti-
meter nodules that undergone FNAC in this study. Meanwhile 
younger age was associated with an increased risk of malignan-
cy. Compared with patients older than 45 yr of age, patients 
younger than 45 yr were more likely to have malignant nodules 
diagnosed with FNAC (OR, 1.327; 95% CI, 1.091-1.613). These 
results suggest that we should pay an attention to the manage-
ment of subcentimeter nodules in younger patients. 
  We believe that our study is very relevant because of its large 
number of including subjects but has some limitation. Our study 
is performed by reviewing medical record retrospectively, and 
FNAC were performed by several different radiologists. Thus 
we could not analyze the detailed sonographic features to pre-
dict the malignancy rate using them, because, for the informa-
tive results, it should be ruled out any possible inconsistency of 
each radiologist’s opinion, even if it is not so big. We expect that 
further analysis with detailed sonographic features by single ex-
pert radiologist in categorized subcentimeter nodules will pro-
vide more useful information.
  In summary, the malignancy rates of nodules did not decrease 
with decreasing size in subcentimeter nodules which were show-
ing one or more sonographically suspicious findings, while the 
rate of nondiagnostic results was increased with decreasing size. 
However, the inadequacy rate was not so high at the aspect of 
cost-effectiveness. Therefore when we decide to perform FNAC 
in subcentimeter-sized nodules, sonographic findings and oth-
er clinical risk factors should be considered, but we should not Bo YH, et al.  •  Malignancy Rate of FNAC in Subcentimeter Thyroid Nodule
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deal with the nodular size itself as a predictor of malignancy risk. 
To make a consensus about cut-off size of FNAC for subcenti-
meter-sized thyroid nodules, a large-scaled prospective study 
examining recurrence, survival and the quality of life in patients 
of papillary microcarcinoma is warranted.
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Malignancy Rate in Sonographically Suspicious Thyroid Nodules of Less than a 
Centimeter in Size Does Not Decrease with Decreasing Size
Yul Hwang Bo, Hwa Young Ahn, Yun Hee Lee, Ye Jin Lee, Jung Hee Kim, Jung Hun Ohn, Eun Shil Hong, Kyung Won Kim,  
In Kyung Jeong, Sung Hee Choi, Soo Lim, Do Joon Park, Hak Chul Jang, Byung-Hee Oh, Bo Youn Cho, and Young Joo Park
We evaluated the malignancy and nondiagnostic rates using FNAC results in 2,756 thyroid nodules smaller than 1 cm according to 
the subdivided size. Subcentimeter nodules had at least one sonographic finding suggestive of malignancy. The malignancy rates 
of nodules did not decrease with decreasing size in subcentimeter nodules. The rate of nondiagnostic results was increased with 
decreasing size. Therefore when we decide to perform FNAC in subcentimeter-sized nodules, we should consider sonographic 
findings and other clinical risk factors but not the nodular size itself.